A Randomized Intervention of Montelukast for Post-Bronchiolitis: Effect on Eosinophil Degranulation
To access this article, please choose from the options below
Supported in part by a Korean Research Foundation grant to C-K.K. funded by the Korean Government (MOEHRD; KRF-2005-042-E00078) and in part by a research grant from the Investigator-Initiated Studies Program of Merck. Merck & Co., provided the inactive, oral, look-alike granules identical to 4-mg montelukast granules. The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck. The authors declare no conflicts of interest.
PII: S0022-3476(09)01224-4
doi:10.1016/j.jpeds.2009.12.001
© 2010 Mosby, Inc. All rights reserved.
